Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|July 13, 2024
The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosisMenghan Fang, Youfen Lin, Chaorong Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumorsJeany M Rademaker-Lakhai, Catherine Terret, Stephen B Howell, et al.
Biochemical Pharmacology|December 17, 2009
Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatinGiovanni Luca Beretta, Valentina Benedetti, Giacomo Cossa, et al.
Molecular Pharmacology|May 23, 2003
Diazonamide A and a synthetic structural analog: disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulinZobeida Cruz-Monserrate, Hélène C Vervoort, Ruoli Bai, et al.
Molecular Cancer Therapeutics|May 2, 2022
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid LeukemiaWilliam G Rice, Stephen B Howell, Hongying Zhang, et al.
ACS Applied Materials & Interfaces|June 29, 2019
Tumor-Targeting, MicroRNA-Silencing Porous Silicon Nanoparticles for Ovarian Cancer TherapyAlessandro Bertucci, Kang-Hoon Kim, Jinyoung Kang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 15, 2015
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosisKazuki N Sugahara, Pablo Scodeller, Gary B Braun, et al.
ACS Nano|March 30, 2016
Cellular Delivery of Nanoparticles Revealed with Combined Optical and Isotopic NanoscopyMaria T Proetto, Christopher R Anderton, Dehong Hu, et al.
Journal of the American Chemical Society|January 16, 2014
Dynamics of soft nanomaterials captured by transmission electron microscopy in liquid waterMaria T Proetto, Anthony M Rush, Miao-Ping Chien, et al.
Gynecologic Oncology|March 26, 2017
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyDanielle A Jandial, William E Brady, Stephen B Howell, et al.
Pageof 11